Lars Christian Petersen

This inventor holds 25 USPTO granted patents and 2 published patent applications and 4 EPO patents, primarily in Antibody Engineering. Top assignees: Novo Nordisk A/s, Zymogenetics, Inc., Novo Nordisk Healthcare Ag. Active years: 1994-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars Christian Petersen. Retrieved from https://idiyas.com/inventor/lars-christian-petersen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 2)

% Patents Active = 92.0

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.5

ph-index = 11

Forward Citations = 493(Granted Patents)

Location History:

H.o slashed.rsholm, DK (1996 - 1997)
Hørsholm, DK (2001 - 2002)
Horsholm, DK (1994 - 2010)
Hoersholm, DK (1998 - 2020)

Company Filing History:

Novo Nordisk Healthcare Ag

patents

4. 1 out of 3

Novo Nordisk Pharmaceuticals, Inc.

patents

5. 2 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2020

Loading Chart...

Areas of Expertise:

Antibodies

Tissue Factor

Protease Inhibitors

Factor VII

Gene Expression

Cell Migration

Apoptosis

Drug Candidates

Kunitz-Type

Aprotinin

Cell Motility

Intracellular Signaling

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10717784 - Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor (2020-07-21),

2. 10106606 - Targeting tissue factor to activated platelets (2018-10-23),

3. 9896513 - Antibodies capable of specifically binding two epitopes on tissue factor pathway inhibitor (2018-02-20),

4. 9260518 - Antibodies that are capable of specifically binding tissue factor pathway inhibitor (2016-02-16),

5. 9228022 - Antibodies that are capable of specifically binding tissue factor pathway inhibitor (2016-01-05),

6. 7829529 - Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis (2010-11-09),

7. 6858587 - Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis (2005-02-22),

8. 6461610 - Methods for modifying cell motility using factor VIIa or inactivated factor VIIa (2002-10-08),

9. 6268163 - Identification of drug candidates modulating factor VII-mediated intracellular signaling (2001-07-31),

10. 6183743 - Modified factor VII (2001-02-06),

11. 6168789 - Modified factor VII (2001-01-02),

12. 6039944 - Modified Factor VII (2000-03-21),

13. 5997864 - Modified factor VII (1999-12-07),

14. 5861374 - Modified Factor VII (1999-01-19),

15. 5859010 - Factor VII -binding reagent (1999-01-12),

Title: The Innovative Journey of Lars Christian Petersen

Introduction: Lars Christian Petersen, a visionary inventor hailing from Hoersholm, Denmark, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Lars Christian Petersen's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a sustainable energy solution for urban environments, and a medical device aimed at improving patient care.

Career Highlights: With a career spanning over two decades, Lars Christian Petersen has established himself as a leading figure in the world of innovation. His work has been recognized with numerous awards and accolades, showcasing his dedication to pushing the boundaries of technology.

Collaborations: Throughout his career, Lars Christian Petersen has collaborated with top research institutions, leading companies, and brilliant minds in the industry. These collaborations have resulted in groundbreaking inventions that have shaped the technological landscape.

Conclusion: Lars Christian Petersen's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to push the limits of what is possible.

Profile summary based on public USPTO records.